宜通世纪 reported revenue of ¥1.04B for the period ended 2026-06-30, -14.5% year on year. Net income was ¥-0.01B, a -1.2% net margin on a 8.6% gross margin. Free cash flow for the period was ¥-0.04B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥1.04B | -14.5% |
| Gross profit | ¥0.09B | — |
| Operating income | ¥-0.01B | — |
| Net income | ¥-0.01B | — |
| Gross margin | 8.6% | Net margin -1.2% |
| Revenue Q/Q | +8.3% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.95B | 91.4% |
| R&D | ¥0.04B | 3.6% |
| SG&A | ¥0.05B | 5.2% |
| Tax & other | ¥0.00B | 0.0% |
| Item | Amount |
|---|---|
| Total assets | ¥3.40B |
| Total liabilities | ¥1.56B |
| Shareholders' equity | ¥1.84B |
| Equity / assets | 54.2% |
| Operating cash flow | ¥-0.03B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥-0.04B |
| Cash conversion (OCF / net income) | 2204% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
任子行 ・ 天山生物 ・ 戴维医疗 ・ 掌趣科技 ・ 珈伟新能 ・ 博晖创新 ・ 麦捷科技 ・ 海达股份 ・ 同大股份 ・ 硕贝德 ・ 华灿光电 ・ 旋极信息
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies